Macro Group Pharmaceutical S.A.E. (MCRO) Net Income
Net Income
EGP -272.65M
Fiscal year 2023
Net income is the profit remaining after all operating costs, interest and taxes are deducted from revenue — the bottom line of the income statement. A negative figure means the company recorded a loss for that fiscal year.
Net income history
| Fiscal year | Net income | YoY growth | Net margin |
|---|---|---|---|
| 2023 | -272.65M | -256.84% | -51.83% |
| 2022 | 173.84M | 17.51% | 23.83% |
| 2021 | 147.93M | — | 24.89% |
All monetary figures in EGP. Source: Egyptian Exchange via TradingView; annual figures from company disclosures; updated weekly. Prices refresh every 15 minutes during EGX trading hours.